278 related articles for article (PubMed ID: 10398165)
1. Expression of Ep-CAM in normal, regenerating, metaplastic, and neoplastic liver.
de Boer CJ; van Krieken JH; Janssen-van Rhijn CM; Litvinov SV
J Pathol; 1999 Jun; 188(2):201-6. PubMed ID: 10398165
[TBL] [Abstract][Full Text] [Related]
2. BSEP and MDR3: Useful Immunohistochemical Markers to Discriminate Hepatocellular Carcinomas From Intrahepatic Cholangiocarcinomas and Hepatoid Carcinomas.
Fujikura K; Yamasaki T; Otani K; Kanzawa M; Fukumoto T; Ku Y; Hirose T; Itoh T; Zen Y
Am J Surg Pathol; 2016 May; 40(5):689-96. PubMed ID: 26735860
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical detection of bcl-2 protein in normal and pathological human liver.
Charlotte F; L'Herminé A; Martin N; Geleyn Y; Nollet M; Gaulard P; Zafrani ES
Am J Pathol; 1994 Mar; 144(3):460-5. PubMed ID: 8129031
[TBL] [Abstract][Full Text] [Related]
4. Expression of MUC 1 and Ep-CAM in Merkel cell carcinomas: implications for immunotherapy.
Kurzen H; Kaul S; Egner U; Deichmann M; Hartschuh W
Arch Dermatol Res; 2003 Aug; 295(4):146-54. PubMed ID: 12844224
[TBL] [Abstract][Full Text] [Related]
5. Expression of Ep-CAM in cervical squamous epithelia correlates with an increased proliferation and the disappearance of markers for terminal differentiation.
Litvinov SV; van Driel W; van Rhijn CM; Bakker HA; van Krieken H; Fleuren GJ; Warnaar SO
Am J Pathol; 1996 Mar; 148(3):865-75. PubMed ID: 8774141
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression of Ep-CAM protein is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.
Hwang EY; Yu CH; Cheng SJ; Chang JY; Chen HM; Chiang CP
J Oral Pathol Med; 2009 Jan; 38(1):87-93. PubMed ID: 18355175
[TBL] [Abstract][Full Text] [Related]
7. The diagnostic value of arginase-1 immunostaining in differentiating hepatocellular carcinoma from metastatic carcinoma and cholangiocarcinoma as compared to HepPar-1.
Radwan NA; Ahmed NS
Diagn Pathol; 2012 Oct; 7():149. PubMed ID: 23111165
[TBL] [Abstract][Full Text] [Related]
8. Immunostaining for polycomb group protein EZH2 and senescent marker p16INK4a may be useful to differentiate cholangiolocellular carcinoma from ductular reaction and bile duct adenoma.
Sasaki M; Matsubara T; Kakuda Y; Sato Y; Nakanuma Y
Am J Surg Pathol; 2014 Mar; 38(3):364-9. PubMed ID: 24487593
[TBL] [Abstract][Full Text] [Related]
9. Ep-Cam levels in prostatic adenocarcinoma and prostatic intraepithelial neoplasia.
Poczatek RB; Myers RB; Manne U; Oelschlager DK; Weiss HL; Bostwick DG; Grizzle WE
J Urol; 1999 Oct; 162(4):1462-6. PubMed ID: 10492238
[TBL] [Abstract][Full Text] [Related]
10. Expression of Ep-CAM, but not of E48, associates with nodal involvement in advanced squamous cell carcinomas of the larynx.
Romeu C; Farré X; Cardesa A; Nadal A
Histopathology; 2013 May; 62(6):954-61. PubMed ID: 23672314
[TBL] [Abstract][Full Text] [Related]
11. Perinodular ductular reaction/epithelial cell adhesion molecule loss in small hepatic nodules.
Zhang Q; Zhang CS; Xin Q; Ma Z; Liu GQ; Liu BB; Wang FM; Gao YT; Du Z
World J Gastroenterol; 2014 Aug; 20(31):10908-15. PubMed ID: 25152593
[TBL] [Abstract][Full Text] [Related]
12. Expression of Ep-CAM in intestinal metaplasia, gastric epithelial dysplasia and gastric adenocarcinoma.
Joo M; Kim H; Kim MK; Yu HJ; Kim JP
J Gastroenterol Hepatol; 2005 Jul; 20(7):1039-45. PubMed ID: 15955212
[TBL] [Abstract][Full Text] [Related]
13. The expression of Ep-CAM (17-1A) in squamous cell cancers of the lung.
Piyathilake CJ; Frost AR; Weiss H; Manne U; Heimburger DC; Grizzle WE
Hum Pathol; 2000 Apr; 31(4):482-7. PubMed ID: 10821496
[TBL] [Abstract][Full Text] [Related]
14. [Hepatic neoductules].
Fischer HP; Meybehm M; Zhou H; Schoch J
Verh Dtsch Ges Pathol; 1995; 79():36-46. PubMed ID: 8600693
[TBL] [Abstract][Full Text] [Related]
15. Topographical immunohistochemical expression of bcl-2 protein in human liver lesions.
Skopelitou A; Hadjiyannakis M; Alexopoulou V; Krikoni O; Kamina S; Agnantis N
Anticancer Res; 1996; 16(2):975-8. PubMed ID: 8687162
[TBL] [Abstract][Full Text] [Related]
16. Intermediate hepatobiliary cells predict an increased risk of hepatocarcinogenesis in patients with hepatitis C virus-related cirrhosis.
Ziol M; Nault JC; Aout M; Barget N; Tepper M; Martin A; Trinchet JC; Ganne-Carrié N; Vicaut E; Beaugrand M; N'Kontchou G
Gastroenterology; 2010 Jul; 139(1):335-43.e2. PubMed ID: 20399781
[TBL] [Abstract][Full Text] [Related]
17. The biology of the 17-1A antigen (Ep-CAM).
Balzar M; Winter MJ; de Boer CJ; Litvinov SV
J Mol Med (Berl); 1999 Oct; 77(10):699-712. PubMed ID: 10606205
[TBL] [Abstract][Full Text] [Related]
18. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
[TBL] [Abstract][Full Text] [Related]
19. Heparan sulphate proteoglycan expression in human primary liver tumours.
Roskams T; De Vos R; David G; Van Damme B; Desmet V
J Pathol; 1998 Jul; 185(3):290-7. PubMed ID: 9771483
[TBL] [Abstract][Full Text] [Related]
20. Expression of the homophilic adhesion molecule, Ep-CAM, in the mammalian germ line.
Anderson R; Schaible K; Heasman J; Wylie C
J Reprod Fertil; 1999 Jul; 116(2):379-84. PubMed ID: 10615264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]